In Israel today, there is an uncomfortable reality: If we doubled the number of therapists tomorrow, it would not be enough. The demand is too high. The workforce shortage is structural. And one-on-one therapy, while essential, cannot carry a nation living under prolonged stress. Technology in mental health is, therefore, not a luxury. It is a necessary infrastructure.
This is not only an Israeli problem. Around the world, mental health systems are fragmented and under strain. Trauma science itself is still young. PTSD entered formal diagnostic language only in the 1980s, and our understanding of collective and national trauma remains limited.
Scaling trauma care
Since October 7, 2023, and in the months of sirens, reserve duty, funerals, displacement, and uncertainty that followed, Israel has had no choice but to confront this challenge at scale. You cannot respond to national trauma with boutique solutions.
What is emerging is not just another wave of start-ups. It is the early formation of mental health infrastructure.
Israel does have structural advantages. Government, health funds, hospitals, researchers, and innovators are often in direct conversation with one another. The country has longstanding digital health systems and extensive health data. During COVID, we saw how quickly barriers can fall when a national crisis occurs. That same muscle is now being tested in mental health.
Still, we should not confuse activity with maturity. An analysis published in January 2026 by Startup Nation Central, 8400 The Health Network, Bezyl, and ICAR Collective identified approximately 178 Israeli companies working in mental health innovation.
That density is impressive; it’s also misleading, as 80% of them are early-stage. Many are testing for feasibility. Innovation density does not necessarily mean system transformation.
The real question is whether these tools can be integrated safely, rigorously, and on a population scale.
At the ICAR Collective Summit in Tel Aviv in February, the discussion’s tone reflected that shift. The focus was not on pitching apps. It was on partnerships and on embedding tools within clinical systems. We spoke about measuring outcomes and avoiding additional burden on already stretched professionals.
Closing access gaps
Some technologies operate early in the care pathway by bridging the gap between distress, self-care, and formal care. Start-ups Reflect Innovation and Relaxelf.ai are integrating physiological biofeedback into homes and schools to support stress regulation and provide insights to the user or caregiver. They could also be used in therapy settings.
Bishvilenu uses a digital platform to disseminate trauma-regulation resources and peer-based tools to individuals navigating fragmented systems. The layer does not compete with therapy; rather, it lowers the threshold for engagement.
SequelCare is collaborating with Hebrew University and Sheba Beyond to develop a guided digital therapeutic for PTSD that is currently undergoing a randomized controlled trial.
Rather than launching a standalone wellness product, the team embedded structured, evidence-based trauma protocols into a digital workflow designed for use within clinical systems. Academic validation and hospital integration were built in from the start. Scale follows credibility.
The partnership and product, being advanced in memory of Adi Vital-Kaploun, is one of the many new tech initiatives being advanced in the name of a victim of the October 7 massacre.
Innovation is also addressing one of mental health’s longstanding weaknesses: reliance on self-report questionnaires and clinical intuition.
EyeMinders is developing a biometric platform that translates eye-movement patterns into indicators of cognitive and emotional load. By analyzing responses to visual and auditory stimuli, the system generates markers that can support screening, monitoring, and personalization of care. In a field where measurement has lagged behind other areas of medicine, biomarkers could strengthen both clinical precision and regulatory pathways.
Together, these examples illustrate a broader pattern. Israeli trauma tech spans self-regulation, digital triage, objective assessment, validated therapeutics, and peer support. The common denominator is not disruption [innovation] for its own sake. It is integration into real-world systems.
Biological innovation, such as emerging psychedelic-assisted psychotherapy models and other rapid-acting interventions, is also advancing. Here, too, the emphasis is on institutionalization: public hospital delivery, structured therapist training, ethical frameworks, and regulatory alignment. The conversation is not about bypassing psychiatry. It is about strengthening it responsibly.
Systems over start-ups
Health leaders are candid about the remaining challenges. Since October 7, health funds have evaluated dozens of mental health solutions. The pipeline is rich, but integration capacity is limited. A system can absorb only a small number of tools each year. Data exists within HMOs, but cross-system harmonization remains incomplete.
Leadership now means consolidation. Serious conversations are underway about unified case management; reducing bureaucratic duplication; enabling seamless data flows so patients are not required to repeatedly retell traumatic histories; and building near real-time situational awareness of population mental health trends. Digital triage tools accessible at any time can generate structured data and guide step-care pathways more intelligently.
This is less about apps and more about architecture. We recognize the long road ahead. Most of the innovation remains at an early stage. Integration is complex. Research coordination is still evolving.
Yet something meaningful is taking shape.
Israel’s trauma burden creates a proving ground, and the tech development demonstrates both post-traumatic growth and resilience. Few countries combine national urgency, digital health infrastructure, extensive data, and cross-sector collaboration in this way. And mental health is increasingly understood not only as a clinical specialty but also as part of national resilience infrastructure and as a public health priority. Technology is becoming connective tissue, linking self-care to triage, triage to treatment, and individual outcomes to population insight.
The shift from Start-Up Nation to recovery nation is not a slogan. It is an attempt to build systems capable of withstanding prolonged stress. If Israel succeeds, it will not be because it produced the most start-ups but because it learned how to integrate them. By remaining focused on infrastructure rather than headlines, Israel may help define what scalable trauma recovery looks like in the decades ahead. ■
Gila Tolub is the co-founder and executive director of ICAR Collective, Israel’s Collective Action for Resilience, which is dedicated to accelerating trauma healing and advancing mental health resilience through coordinated collaboration across Israel’s public health, NGO, academic, and research communities.